These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 870233)

  • 41. Hormonal and blood pressure changes during converting enzyme inhibition by teprotide.
    VandenBurg MJ; Sharman VL; Morton JJ; Williams GH; Marsh FP
    Postgrad Med J; 1981 May; 57(667):283-8. PubMed ID: 6170971
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Angiotensin II effect on plasma steroids in selective hypoaldosteronism.
    Lebel M; Grose JH
    Horm Metab Res; 1982 Aug; 14(8):432-6. PubMed ID: 7129353
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Studies on the pathophysiology of pregnancy induced hypertension--endocrinological analysis by the method of angiotensin II and NaCl loading].
    Yamasaki M; Morikawa H; Mochizuki M
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Nov; 37(11):2315-24. PubMed ID: 3908589
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Effect of 17-alpha-hydroxyprogesteronecapronate on sodium excretion and the renin-angiotensin-aldosterone-system in humans].
    Kaulhausen H; Bolle EB; Mühlbauer W; Benker G; Berg R; Liappis N; Breuer H
    Endokrinologie; 1979 Feb; 73(1):33-46. PubMed ID: 467359
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Endogenous angiotensin II as a determinant of sodium-modulated changes in tissue responsiveness to angiotensin II in normal man.
    Shoback DM; Williams GH; Hollenberg NK; Davies RO; Moore TJ; Dluhy RG
    J Clin Endocrinol Metab; 1983 Oct; 57(4):764-70. PubMed ID: 6309884
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Angiotensin-converting enzyme gene polymorphism has no influence on the circulating renin-angiotensin-aldosterone system or blood pressure in normotensive subjects.
    Lachurié ML; Azizi M; Guyene TT; Alhenc-Gelas F; Ménard J
    Circulation; 1995 Jun; 91(12):2933-42. PubMed ID: 7796503
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prolonged infusions of Ile5-angiotensin-II in sodium replete and deplete man: effects on aldosterone, ACTH, cortisol, blood pressure, and electrolyte balance.
    Oelkers W; Schöneshöfer M; Schultze G; Wenzler M; Bauer B; L'age M; Fehm HL
    J Clin Endocrinol Metab; 1978 Mar; 46(3):402-13. PubMed ID: 221518
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Primacy of the renin-angiotensin system in mediating the aldosterone response to sodium restriction.
    Swartz SL; Williams GH; Hollenberg NK; Dluhy RG; Moore TJ
    J Clin Endocrinol Metab; 1980 Jun; 50(6):1071-4. PubMed ID: 6989849
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of sodium restriction and prostaglandin inhibition on the renin-angiotensin system in man.
    Speckart P; Zia P; Zipser R; Horton R
    J Clin Endocrinol Metab; 1977 May; 44(5):832-7. PubMed ID: 870512
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A specific role for saline or the sodium ion in the regulation of renin and aldosterone secretion.
    Tuck ML; Dluhy RG; Williams GH
    J Clin Invest; 1974 Apr; 53(4):988-95. PubMed ID: 4360859
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Decreased vascular and increased adrenal and renal sensitivity to angiotensin II in the newborn lamb.
    Siegel SR
    Circ Res; 1981 Jan; 48(1):34-8. PubMed ID: 7002347
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acute effects of oral glucose loading on the renin-angiotensin-aldosterone system in patients with chronic renal disease.
    Uemasu J; Fujihara M; Matsumoto T; Kawasaki H
    Horm Metab Res; 1993 Feb; 25(2):110-3. PubMed ID: 8458606
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The acute effects of the new angiotensin I-converting enzyme inhibitor, enalapril maleate, on blood pressure, plasma renin, aldosterone and kinins in hypertensive patients].
    Gotoh M; Mizuno K; Hashimoto S; Kunii N; Fukuchi S
    Nihon Naibunpi Gakkai Zasshi; 1985 May; 61(5):619-29. PubMed ID: 2991035
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The renin-angiotensin-aldosterone system in the newborn lamb: response to furosemide.
    Siegel SR; Fisher DA
    Pediatr Res; 1977 Jul; 11(7):837-9. PubMed ID: 876706
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Selective hypoaldosteronism with hyperreninemia in a diabetic patient.
    Morimoto S; Kim KS; Yamamoto I; Uchida K; Takeda R; Kornel L
    J Clin Endocrinol Metab; 1979 Nov; 49(5):742-7. PubMed ID: 489714
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Changes of electrolyte excretion, renin activity, angiotensin-II and aldosterone concentrations during administration of 3-amino-1-(3,4-dichloro-a-methyl-benzyl)-2-pyrazolin-5-one (Bay g 2821).
    Schnurr E; Küppers H
    Int J Clin Pharmacol Biopharm; 1979 Nov; 17(11):453-6. PubMed ID: 511420
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of the oral converting enzyme inhibitor, SQ 14225, in a model of low cardiac output in dogs.
    Freeman RH; Davis JO; Williams GM; DeForrest JM; Seymour AA; Rowe BP
    Circ Res; 1979 Oct; 45(4):540-5. PubMed ID: 225056
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Central effects of angiotensin II and dopamine in sodium-depleted sheep.
    Huang BS; Malvin RL; Grekin RJ
    Am J Physiol; 1985 May; 248(5 Pt 2):R541-8. PubMed ID: 3887949
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Responses of plasma bradykinin and the renin angiotensin axis to angiotensin II in hyperthyroid patients].
    Takeda Y; Miyamori I; Ikeda M; Koshida H; Yasuhara S; Morise T; Okamoto S; Kawato M; Takeda R
    Nihon Naibunpi Gakkai Zasshi; 1986 Feb; 62(2):61-8. PubMed ID: 3009241
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ontogeny of the renin-angiotensin-aldosterone system in the fetal and newborn lamb.
    Siegel SR; Fisher DA
    Pediatr Res; 1980 Feb; 14(2):99-102. PubMed ID: 6987603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.